Progress in the Management of Multiple Sclerosis
Multiple Sclerosis (MS) presents a challenge to insurers due to its complex, unpredictable course.
Multiple Sclerosis (MS) presents a challenge to insurers due to its complex, unpredictable course.
It may become even more challenging to underwrite applicants with Multiple Sclerosis (MS), and that is positive news for patients. Medical advances are outpacing mortality data so swiftly that, within the decade, it could be possible for the majority of applicants to be prescribed medications for which there are currently no long-term experience studies.
Slides from the 2016 SEHOUA Meeting have been posted. They include:
https://www.ahou.org/ContentManagement/ContentShow.aspx?s=FFx04kWZTrk=
“From Pariah to Prescription” was the title of a review that appeared some years ago on the possible medical use of marijuana. What then seemed utopian and provocative has now become reality! A recently published comprehensive meta-analysis came to the conclusion that the muscle relaxant and analgesic effects of THC in cases of multiple sclerosis (MS) were well documented.
http://www.genre.com/knowledge/publications/uwfocus16-1-vaney-en.html